PRI Research, through its integrated organization M3 Wake Research, focuses on advancing healthcare by conducting clinical trials that evaluate new investigational medications, therapies, and medical devices. With over 30 years of experience, the organization has successfully completed 264 studies and engaged more than 19,000 participants. Their clinical trials aim to enhance patient care by identifying effective treatments and preventive measures, while also providing participants with access to world-class medical professionals and individualized care. The organization emphasizes a patient-centric approach, ensuring that participants receive thorough explanations of procedures and are well-informed throughout their involvement in the trials.

The clinical trial process at PRI Research is designed to maintain the highest ethical standards and privacy for participants. They recruit and qualify volunteers for a diverse range of studies, ensuring that the integrity of each trial is upheld, regardless of the number of locations involved. The organization utilizes advanced diagnostic equipment and rigorous data collection methods to analyze results, providing valuable insights into the efficacy and safety of new treatments. By partnering with biopharmaceutical and clinical research organizations, PRI Research plays a crucial role in the ongoing advancement of medical knowledge and the improvement of healthcare outcomes.

On September 27, 2018, M3 Wake Research Network Acquires Pharmacology Research Institute (PRI)

United States

Pharmacology Research Institute is a healthcare organization that focuses on meeting patient needs through quality care and improved access to investigational treatments.

PRI Research

Company Details